Brain-Tropic Metastasis: Mechanistic Checkpoints Governing Cerebral Colonization.

BACKGROUND: Brain metastasis is a major contributor to morbidity in advanced cancer, with substantial variability in incidence and biological behavior across primary tumor types and molecular subtypes. Increasing evidence suggests that cerebral organotropism is driven by coordinated interactions between tumor-intrinsic programs and the specialized brain microenvironment. This review aimed to synthesize contemporary mechanistic evidence underlying brain-tropic metastasis and identify biologically actionable bottlenecks involved in metastatic progression within the central nervous system. SUMMARY: We conducted a mechanism-focused narrative review of recent neuro-oncology literature examining the biological processes that facilitate brain-specific metastatic dissemination. Four major mechanistic domains were evaluated: (1) extracellular vesicle and exosome-mediated conditioning of the brain vascular-immune niche; (2) cerebral microvascular arrest and endothelial adhesion under shear stress facilitating tumor transmigration; (3) brain-tumor barrier remodeling and endothelial-state heterogeneity influencing permeability and transport; and (4) perivascular metastatic progression shaped by astrocytic and microglial/myeloid microenvironments. The strongest mechanistic support for cerebral organotropism was identified in breast cancer, oncogene-driven non-small cell lung cancer, and melanoma. In contrast, the biological pathways underlying brain metastasis in renal cell carcinoma and colorectal cancer remain comparatively less defined. KEY MESSAGES: Cerebral organotropism appears to emerge through iterative tumor subclone evolution coupled with dynamic host microenvironmental reprogramming. Coordinated vascular, immune, and glial interactions represent critical mechanistic checkpoints governing metastatic seeding and survival in the brain. Future advances in prediction and prevention will require subtype-resolved and spatially informed human validation studies, alongside mechanistically grounded therapeutic strategies targeting vascular docking, barrier remodeling, and glial-myeloid support pathways.